04/22/2024
12:06 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2024
6:29 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
6:03 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/05/2024
11:18 AM | BlackRock Inc. (Filed by)
Legend Biotech (Subject)
| Form SC 13G/A | |
03/29/2024
7:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2024
4:22 PM | Ji Darren Xiaohui (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024
3:57 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/19/2024
10:09 AM | Legend Biotech (Subject)
Yau Wai Man Philip (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024
6:57 AM | Legend Biotech (Filer)
| Form F-3ASR | |
03/19/2024
6:02 AM | Legend Biotech (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/15/2024
2:18 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2024
7:36 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024
6:52 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2024
5:46 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144/A | |
02/28/2024
4:35 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
6:47 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
12:10 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
6:16 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
7:34 PM | GenScript Biotech Corp (Filed by)
Legend Biotech (Subject)
| Form SC 13G/A | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Legend Biotech (Subject)
| Form SC 13G | |
01/23/2024
8:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/23/2024
6:30 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023
9:00 AM | Legend Biotech (Subject)
Yau Wai Man Philip (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
2:38 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
2:21 PM | Legend Biotech (Subject)
Macomber Lori (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/21/2023
4:17 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023
1:31 PM | Heyman Tomas J. (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2023
5:02 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2023
7:30 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/17/2023
4:39 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2023
4:50 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144/A | |
10/17/2023
7:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2023
4:20 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2023
11:02 AM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2023
7:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/22/2023
3:10 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/22/2023
3:20 PM | Legend Biotech (Subject)
Macomber Lori (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023
3:41 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2023
9:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/23/2023
3:27 PM | Legend Biotech (Subject)
Sanders Corazon D. (0001796536) (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023
5:10 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad) The latest flare-up between Israel and Palestinian militants has sent gold prices surging.
Why? Because savvy investors know the endgame of the elites at play…
Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
 See why the elites are pouring billions into gold. |
07/20/2023
7:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2023
9:30 AM | Legend Biotech (Subject)
Yau Wai Man Philip (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
12:45 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2023
3:44 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2023
2:00 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
10:17 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023
3:18 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/26/2023
8:01 AM | Legend Biotech (Filer)
| Form F-3ASR | |
05/25/2023
7:30 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/18/2023
7:30 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2023
7:39 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2023
8:45 AM | FMR LLC (Filed by)
Legend Biotech (Subject)
| Form SC 13G/A | |
05/08/2023
7:45 AM | Legend Biotech (Filer)
| Form 424B5 | |
05/08/2023
7:46 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
